Results 171 to 180 of about 4,298,444 (380)

Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV) [PDF]

open access: bronze, 1987
Stephen Dewhurst   +5 more
openalex   +1 more source

Cerebrospinal Fluid Metabolome in Central Nervous System Infections: A Study of Diagnostic Accuracy

open access: yesAnnals of Neurology, EarlyView.
Objective To assess the diagnostic accuracy of metabolites in cerebrospinal fluid (CSF) for central nervous system (CNS) infections. Methods Patients were derived from three prospective cohort studies in the Netherlands. All studies included adults suspected of a CNS infection who underwent a diagnostic lumbar puncture.
Steven L. Staal   +7 more
wiley   +1 more source

Identification of novel neutralizing determinants for protection against HCV

open access: yesHepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua   +12 more
wiley   +1 more source

An Electrochemical Sensor for Tenofovir Monitoring

open access: yesAdvanced NanoBiomed Research, EarlyView.
A novel laser‐scribed graphene/ gold spiky nanostructures/molecularly imprinted polymer electrochemical sensor is developed for sensitive and selective detection of tenofovir (TFV) to support human immunodeficiency virus adherence monitoring. It showed a broad linear range (10 nM–200 μM), low detection limit (3 nM), and high recovery (92.5%–113%) in ...
Abdellatif Ait Lahcen, Gymama Slaughter
wiley   +1 more source

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

open access: yesHepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger   +7 more
wiley   +1 more source

Progressive neurological dysfunction during latent HIV infection. [PDF]

open access: bronze, 1989
Janus Christian Jakobsen   +4 more
openalex   +1 more source

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

open access: yesArthritis &Rheumatology, EarlyView.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy